This Week in Transparency News: November 7 – November 20, 2020

by Staff Writer, Posted on November 20, 2020

Clinical trial transparency in the pharmaceutical industry is continually evolving, and to stay on top of the news, TrialAssure brings a bi-weekly round-up of some of the key stories. Select recent and relevant stories are as follows:

FDA commits to data transparency in COVID EUAs – RAPS.org

As the time draws near for the leaders in the global race for a vaccine against COVID-19 to submit emergency use authorization (EUA) authorizations to the US Food and Drug Administration (FDA), the agency has proclaimed a new commitment to transparency. FDA commissioner Stephen Hahn, MD, said, “I am announcing today that our drug and biological product centers intend, to the extent appropriate and permitted by law, to publicly post their reviews of the scientific data and information supporting the issuance, revision or revocation of EUAs for all drug and biological products, including vaccines, as part of our COVID-19 response…”

Read more on raps.org

Latest NORD Webinar Offers Insights on Starting Nonprofit, Patient Registry smanewstoday.com

Leaders in the U.S. rare disease community came together recently for a webinar to present helpful information on how to start a nonprofit and patient registry. In this coming together webinar, each organization discussed the benefits of creating patient registries and how they can help accelerate research, during a presentation titled Take the Leap! Forming a 501(c)(3) & Establishing a Disease Registry to Advance Your Rare Community.

Read more on smanewstoday.com

Latest Release of TrialAssure ANONYMIZE for Documents Saves up to 80 Percent of Effort in PDF Document Anonymization and Redaction for Regulated Pharmaceutical Industry Documents – TrialAssure

TrialAssure® – a leading, global software company advancing clinical trial disclosure and data transparency – has released its latest version of ANONYMIZE for Documents, including the functionality to anonymize and redact PDF documents concurrently. This update to TrialAssure’s previous version of ANONYMIZE is a first-in-class redaction software that will allow quicker and more efficient editing process for preparing shareable, compliant documents.

Read more on TrialAssure.com

< Back to all News